Free Trial

Enovix (NASDAQ:ENVX) Stock Price Down 5%

→ A Silent Invasion of America (From The Freeport Society) (Ad)
Enovix logo with Oils/Energy background

Enovix Co. (NASDAQ:ENVX - Get Free Report) was down 5% during trading on Thursday . The company traded as low as $10.03 and last traded at $10.05. Approximately 1,061,304 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 4,950,697 shares. The stock had previously closed at $10.58.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ENVX shares. Craig Hallum decreased their price target on shares of Enovix from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Thursday, May 2nd. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $30.00 price objective on shares of Enovix in a report on Thursday, April 25th. JPMorgan Chase & Co. dropped their target price on Enovix from $18.00 to $12.00 and set an "overweight" rating for the company in a report on Friday, April 26th. William Blair reaffirmed an "outperform" rating on shares of Enovix in a research note on Thursday, May 2nd. Finally, Canaccord Genuity Group reiterated a "buy" rating and set a $17.00 price objective on shares of Enovix in a research note on Wednesday, February 21st. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.33.

Check Out Our Latest Research Report on Enovix

Enovix Stock Performance

The stock has a market cap of $1.63 billion, a P/E ratio of -7.17 and a beta of 1.70. The stock has a fifty day simple moving average of $7.96 and a 200-day simple moving average of $9.99. The company has a quick ratio of 4.77, a current ratio of 4.89 and a debt-to-equity ratio of 0.72.


Enovix (NASDAQ:ENVX - Get Free Report) last posted its earnings results on Wednesday, May 1st. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.34) by ($0.05). Enovix had a negative return on equity of 85.47% and a negative net margin of 1,448.90%. The firm had revenue of $5.27 million during the quarter, compared to analyst estimates of $4.16 million. Equities analysts expect that Enovix Co. will post -1.15 earnings per share for the current fiscal year.

Insider Activity at Enovix

In other Enovix news, COO Ajay Marathe sold 4,954 shares of Enovix stock in a transaction that occurred on Sunday, April 14th. The shares were sold at an average price of $7.31, for a total value of $36,213.74. Following the transaction, the chief operating officer now owns 978,913 shares of the company's stock, valued at $7,155,854.03. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 17.30% of the stock is owned by insiders.

Institutional Trading of Enovix

Institutional investors and hedge funds have recently bought and sold shares of the stock. Virtu Financial LLC acquired a new stake in shares of Enovix in the 1st quarter valued at approximately $88,000. Beacon Capital Management LLC grew its position in shares of Enovix by 71.9% in the 1st quarter. Beacon Capital Management LLC now owns 4,298 shares of the company's stock valued at $34,000 after acquiring an additional 1,798 shares during the period. Adalta Capital Management LLC increased its stake in shares of Enovix by 18.1% during the 1st quarter. Adalta Capital Management LLC now owns 54,231 shares of the company's stock worth $434,000 after purchasing an additional 8,320 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in Enovix in the 1st quarter valued at about $85,000. Finally, Avenir Corp lifted its stake in Enovix by 12.2% in the 1st quarter. Avenir Corp now owns 28,730 shares of the company's stock valued at $230,000 after purchasing an additional 3,135 shares during the last quarter. Institutional investors own 50.92% of the company's stock.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Recommended Stories

Should you invest $1,000 in Enovix right now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines